Immuneering Corporation
$4.85
-0.14 (-2.81%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +16.3%
- 3 Months
- +13.3%
- YTD
- -26.3%
- 1 Year
- -15.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 90.0%
- Largest decline max drawdown, since Aug 2025
- -57.7%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.30
Own IMRX?
See how IMRX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.